omega-3-acid ethyl esters 90 (TAK-085)
TAK-085/OCT-001
Phase 3 small_molecule completed
Quick answer
omega-3-acid ethyl esters 90 (TAK-085) for Hypertriglyceridemia is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 2 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Hypertriglyceridemia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed